Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Pharmacyclics LLC.
Pharmacyclics LLC.
SWOG Cancer Research Network
University of Chicago
Eli Lilly and Company
The Lymphoma Academic Research Organisation
Universität des Saarlandes
Incyte Corporation
Celgene
Janssen Research & Development, LLC
Celgene
University of Liverpool
Mayo Clinic
Cyteir Therapeutics, Inc.
BeiGene
M.D. Anderson Cancer Center
University of Rochester
University of Giessen
Nordic Nanovector
University College, London
City of Hope Medical Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
University of Nebraska
National Cancer Institute (NCI)
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Hoffmann-La Roche
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Brown University
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
Alexion Pharmaceuticals, Inc.
CTI BioPharma
National Cancer Institute (NCI)
Universität des Saarlandes
SymBio Pharmaceuticals
Hoffmann-La Roche
Universität des Saarlandes
Universität des Saarlandes
Dartmouth-Hitchcock Medical Center
Sandoz
Celltrion
Oslo University Hospital
European Organisation for Research and Treatment of Cancer - EORTC
SWOG Cancer Research Network
M.D. Anderson Cancer Center
University of Washington
Archigen Biotech Limited